| The Canadian
Patient Safety Institute |
- An independent
not-for-profit corporation, CPSI performs a coordinating and leadership role across health sectors and
systems, promotes effective strategies and leading practices to improve patient safety, and raises awareness
with stakeholders, patients and the general public about patient safety. CPSI has a national mandate to build
and advance a safer health system for Canadians. The Institute provides leadership on patient safety issues,
and helps to create a culture that is open to disclosure and committed to change that will improve care. By
supporting healthcare professionals in their development and implementation of patient safety programs, such
as Safer Healthcare Now! CPSI helps promote innovative
and successful evidence-based strategies for improving patient safety. In addition to supporting and working with
several Canadian health organizations on patient safety initiatives, CPSI has established a funding environment
for research and analysis that encourages the exploration, exposure and resolution of patient safety issues.
|
The Institute
for Safe Medication Practices of
Huntingdon Valley, PA (ISMP) |
- ISMP Canada is a partner of ISMP
in the US; a representative of ISMP will serve as a trustee. ISMP
has agreed to provide a full range of logistic and resource support
to ISMP Canada, including use of material published in the ISMP
Medication Safety Alert!, a biweekly email and fax alert publication
sent to all US hospitals. ISMP has pledged use of their database
of published events and recommendations, and will provide consultative
support and tools already developed by ISMP for use in error prevention.
A contractual agreement has been developed to outline the working
relationship between these two organizations.
|
| Health Canada |
The Canadian Medication Incident
Reporting and Prevention System (CMIRPS) has been developed through
the collaborative efforts of Health Canada, the Institute for Safe
Medication Practices Canada (ISMP Canada) and the Canadian Institute
for Health Information (CIHI), with input from stakeholders across
Canada. Discussions continue with the Canadian Patient Safety Institute
to help ensure that CMIRPS is coordinated with other patient safety
initiatives.
The aim of CMIRPS is to strengthen Canada's capacity to reduce and prevent harmful medication incidents and to manage and share information about voluntarily reported medication incidents. CMIRPS is designed to complement Health Canada's postmarket surveillance program, the Canadian Adverse Drug Reaction Monitoring Program. The Health Product InfoWatch (InfoWatch) [previously known as the Canadian Adverse Reaction Newsletter (CARN)] informs health care professionals of new safety information detected through the review of adverse reaction reports submitted to Health Canada. Visit the MedEffectTM Canada web site at www.health.gc.ca/medeffect to view or to subscribe for free to the InfoWatch.
|
Canadian Standards
Association International |
- ISMP Canada will form a partnership
with Canadian Standards Association International (CSA) to share
ideas and data regarding medication errors, especially those involving
drug names, packaging, containers and labels. ISMP Canada will provide
input into development of standards for medical devices, drug containers,
packaging and labels as required.
|
Canadian Association of Provincial Cancer Agencies (CAPCA) |
|
| Professional
Organizations |
- ISMP Canada is a multidisciplinary
nonprofit organization promoting patient safety through the reduction
of error-induced injury. On a professional level, ISMP Canada has
been successful in seeking formal collaboration and support from
the Canadian Pharmacists Association, the Canadian Society of Hospital
Pharmacists and the Canadian Nurses Association. An effort is underway
to link with the Canadian Medical Association and the Royal College
of Physicians and Surgeons of Canada.
|
Canadian Society of Hospital Pharmacists (CSHP) |
- The Canadian Society of Hospital Pharmacists and ISMP Canada have
signed a Memorandum of Understanding to formally recognize their close working relationship and
their mutual commitment to collaborate for the advancement of patient safety. CSHP has a lengthy
history of leadership in the advancement of safe medication practices, including the promotion of
safe drug distribution systems, the advancement of pharmacists' involvement in direct patient
care and the active membership in the Canadian Coalition on Medication Incident Reporting and
Prevention. CSHP has also played a major role in the development of standards for drug labelling
and packaging. The development of the Canadian Medication Incident Reporting
and Prevention System (CMIRPS) places ISMP Canada is in a unique position to assume a lead in
the area of enhanced drug labelling and packaging. This will allow CSHP to concentrate on the
direct patient care role of hospital pharmacists - a key component in patient safety.
|
HealthCareCAN |
- ISMP Canada is in the process of
establishing partnership with HealthCareCAN. Collaborative
efforts include HealthCareCAN disseminating information for ISMP Canada, facilitating
and fostering ISMP Canada's working relationship with the provincial
hospital associations. HealthCareCAN will also consider participating in other
initiatives and projects that help Canadian healthcare institutions
to implement strategies to prevent or reduce injuries to patients
due to medication use.
|
| Canadian Nurses
Association |
- ISMP Canada has formed a partnership
with the Canadian Nurses Association. In addition to the web site
links of the two organizations, CNA will promote ISMP Canada's safe
medication practices philosophy to its members. CNA will also consider
having an ISMP Canada column printed in one of their publications.
|
Ontario Hospital
Association (OHA) |
- ISMP Canada has established a working
relationship with the Ontario Hospital Association, the largest
hospital association in Canada. Similar to CHA, OHA will disseminate
important initiatives information to Ontario hospitals, and will
organize joint educational workshops and sessions on safe medication
practices. ISMP Canada will have a continuing dialogue with OHA
to develop tools and strategies on implementing safe medication
practice initiatives for hospitals in Ontario.
|
Healthcare Insurance
Reciprocal of Canada (HIROC) |
- Healthcare Insurance Reciprocal
of Canada (HIROC) is the largest healthcare liability insurer in
Canada. HIROC's member-owners (Subscribers) include hospitals, nursing
homes, community health centres, community care access centres and
other health-related organizations. HIROC is committed to maximize
the quality of healthcare delivery in Canada, and works proactively
with its Subscribers to prevent error and reduce claims. ISMP Canada
has a working relationship with
HIROC, who shares ISMP Canada's philosophy and vision of patient
safety and sponsors the ISMP Canada Safety Bulletin.
|
| Canadian Addison Society |
- A registered National charity organization, the Canadian Addison Society provides support to people with Addison's Disease and Secondary Adrenal Insufficiency (SAI), and their families. The association seeks to educate the public and medical professionals by providing information regarding aspects of the disease. The Society connects those newly diagnosed with Addison's and SAI with education, support groups, and the opportunity to network with experienced peers. After having the privilege to speak at a support group meeting, ISMP Canada and the Canadian Addison Society will continue to work together to promote safe medication use for those with Addison's and SAI.
|
| Other Organizations |
- ISMP Canada will explore an ongoing
working relationship with the pharmaceutical industry and the Canadian
Institute of Health Information. It will also form a working relationship
with the National Patient Safety Foundation founded by the American
Medical Association.
|
Representation
by the Public (Patients) |
- A lay person representative of the
public will be a member of the Board of Trustees.
|
